OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages
Jincheng Wang, Jialu Jin, Ting Chen, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4345-4345
Open Access | Times Cited: 11

Showing 11 citing articles:

Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 152

Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications
Sicheng Zhai, Rui Wang, Jingyuan Wang, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1659-1704
Closed Access | Times Cited: 8

Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6

Advancements in Osteosarcoma Therapy: Overcoming Chemotherapy Resistance and Exploring Novel Pharmacological Strategies
Mahmoud Zhra, Shahid Akhtar Akhund, Khalid S. Mohammad
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 520-520
Open Access

The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles
Xinxin Meng, Feng‐Yun Ma, Dingli Yu
Environmental Research (2023) Vol. 240, pp. 117362-117362
Closed Access | Times Cited: 10

Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters
Sara R. Martins‐Neves, Gabriela Sampaio-Ribeiro, Célia Gomes
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11416-11416
Open Access | Times Cited: 9

Curcumol Reduces Aerobic Glycolysis and Overcomes Chemoresistance by Inducing Cdh1-Mediated Skp2 Ubiquitination
Yu Gan, Li Zhou, Ruike Wang, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 03, pp. 723-740
Closed Access | Times Cited: 5

The Roles of Exosomes in Metastasis of Sarcoma: From Biomarkers to Therapeutic Targets
Linyun Tan, Yitian Wang, Xin Hu, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 456-456
Open Access | Times Cited: 4

Advances in drug resistance of osteosarcoma caused by pregnane X receptor
Kunhong Mao, Can Liu, Zhongwen Tang, et al.
Drug Metabolism Reviews (2024), pp. 1-14
Closed Access | Times Cited: 1

Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy
Yun Liu, Yunhua Lin, Shijie Liao, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23601-e23601
Open Access | Times Cited: 2

Page 1

Scroll to top